10x Genomics, Inc. (TXG)
Data as of , from SEC Form 4 filings.
See up to 3 months of TXG. The 7-day demo opens the 1M and 3M ranges and puts TXG on your watchlist.
Start 7-day demoLatest TXG insider trades
About 10x Genomics, Inc. (TXG)
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
- PLEASANTON, CA
- 1,178
- 2019
- XNAS
TXG Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 28 | 186,884 | $12.24M |
| Bona-fide gift | 2 | 4,100 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
TXG insider transactions (Form 4)
2147 Form 4 filings on record, the earliest from Nov 18, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Sarah A. Teichmann | Open-market sale | Class A Common Stock | 7,579 | $19.41 | $147K | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 9,632 | $18.58 | $179K | |
| Adam Taich - Officer | Open-market sale | Class A Common Stock | 8,968 | $18.58 | $167K | |
| Benjamin J. Hindson - Officer | Open-market sale | Class A Common Stock | 7,826 | $18.58 | $145K | |
| Serge Saxonov - Officer | Option exercise | Class A Common Stock | 50,000 | $1.20 | $60K | |
| Serge Saxonov - Officer | Option exercise | Stock Option (right to buy) | 17,463 | $0.00 | - | |
| Serge Saxonov - Officer | Option exercise | Stock Option (right to buy) | 32,537 | $0.00 | - | |
| Adam Taich - Officer | Open-market sale | Class A Common Stock | 11,888 | $19.00 | $226K | |
| Benjamin J. Hindson - Officer | Open-market sale | Class A Common Stock | 8,283 | $19.00 | $157K | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 13,261 | $19.00 | $252K | |
| Serge Saxonov - Officer | Gift | Class A Common Stock | 900 | $0.00 | - | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 9,348 | $13.79 | $129K | |
| Adam Taich - Officer | Open-market sale | Class A Common Stock | 22,315 | $13.79 | $308K | |
| Benjamin J. Hindson - Officer | Open-market sale | Class A Common Stock | 7,486 | $13.79 | $103K | |
| John R. Stuelpnagel | Grant or award | Class A Common Stock | 15,357 | $0.00 | - | |
| Serge Saxonov - Officer | Option exercise | Class A Common Stock | 12,000 | $1.20 | $14K | |
| Serge Saxonov - Officer | Option exercise | Stock Option (right to buy) | 12,000 | $0.00 | - | |
| Serge Saxonov - Officer | Gift | Class A Common Stock | 1,850 | $0.00 | - | |
| Serge Saxonov - Officer | Open-market sale | Class A Common Stock | 6,693 | $13.69 | $92K | |
| Benjamin J. Hindson - Officer | Open-market sale | Class A Common Stock | 5,807 | $13.69 | $79K | |
| Serge Saxonov - Officer | Gift | Class A Common Stock | 1,350 | $0.00 | - |
Recent TXG Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Shehnaaz Suliman | Affiliate | 5,723 | $453K | View on EDGAR | |
| ADAM TAICH | Officer | 46,388 | $3.00M |
TXG insider trading FAQ
What is the latest insider trade for TXG?
10x Genomics, Inc. (TXG) had 13 insider filings in the last 90 days, with the most recent on 2026-09-24. The full record for TXG runs to 47 Form 4 filings, the earliest from 2024-11-18. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TXG stock?
No insider purchases of TXG were filed in the last 90 days.
How many insiders are selling TXG stock?
28 insider sales of TXG were filed in the last 90 days, totaling $12.24M.
Where can I see TXG SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TXG Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Shehnaaz Suliman view on EDGAR
- - Serge Saxonov view on EDGAR
- - Adam Taich view on EDGAR
- - John R. Stuelpnagel view on EDGAR
- - Serge Saxonov view on EDGAR
- - Serge Saxonov view on EDGAR
- - Serge Saxonov view on EDGAR
- - Adam Taich view on EDGAR
- - Benjamin J. Hindson view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where TXG's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TXG with a 7-day demo
- TXG on your watchlist
- Every TXG Form 4 filing on record
- Up to 3 months of TXG price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
